Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
06/2003
06/04/2003EP1316312A1 Use of the Hibiscus sabdariffa extract in the preparation of a medicament
06/04/2003EP1315965A2 Methods and compositions for in vitro targeting
06/04/2003EP1315840A2 Biopanning and rapid analysis of selective interactive ligands (brasil)
06/04/2003EP1315831A2 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents
06/04/2003EP1315830A2 Compositions and methods for targeting peptides in humans in vivo
06/04/2003EP1315804A2 Novel mmp-2 derivatives for use as inhibitors of integrin alpha vbeta 3
06/04/2003EP1315800A2 Human proteases
06/04/2003EP1315758A2 Methods and reagents for protease inhibition
06/04/2003EP1315750A2 Cyclic peptides having melanocortin-4 receptor agonist activity
06/04/2003EP1315749A2 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport
06/04/2003EP1315735A1 Phosphate derivatives as immunoregulatory agents
06/04/2003EP1315731A1 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives
06/04/2003EP1315730A1 1-(alkyl), 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-pyridinyl-imidazo(1,2-a)pyrimidin-5(1h)-one derivatives
06/04/2003EP1315727A2 7-oxo pyridopyrimidines
06/04/2003EP1315724A1 A thiazolidinedione derivative and its use as antidiabetic
06/04/2003EP1315723A1 The hydrochloride salt of 5[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
06/04/2003EP1315722A1 Thiazolidinone nitrate salt
06/04/2003EP1315721A1 A thiazolidinedione derivative and its use as antidiabetic
06/04/2003EP1315695A2 Benzene tricarboxylic acid amides as insulin receptor activators
06/04/2003EP1315694A2 Inhibitors of alpha 4 mediated cell adhesion
06/04/2003EP1315517A1 Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same
06/04/2003EP1315512A2 Adenoviral targeting and manipulation of immune system response using targeting peptides
06/04/2003EP1315504A1 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications
06/04/2003EP1315502A1 Method for treating erectile dysfunction and increasing libido in men
06/04/2003EP1315501A1 Alpha v integrin receptor antagonists
06/04/2003EP1315482A2 Water-dispersible encapsulated sterols
06/04/2003EP1252150B1 Heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
06/04/2003EP1196444B1 Extendin-4 conjugates and their medical use
06/04/2003EP1162995B1 Enzymes for the treatment of diabetes mellitus type i
06/04/2003EP1140945B1 Fused 1,2,4-thiadiazine derivatives, their preparation and use
06/04/2003EP1140186B1 Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
06/04/2003EP1140185B1 Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
06/04/2003EP1140184B1 Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
06/04/2003EP1121121B1 Methods for inhibiting diabetic complications
06/04/2003EP1095007B1 Water-soluble zinc pyruvates or their hydrates, method for the production thereof and their use
06/04/2003EP1038863B1 Substituted dimeric compounds, process for their preparation and pharmaceutical compositions thereof
06/04/2003EP1027363B1 Adenosine a1-receptor agonists
06/04/2003EP0817641B1 Substances extracted from dictyotales, preparation method therefor, and compositions containing same
06/04/2003EP0775118B1 Benzimidazole derivatives having dopaminergic activity
06/04/2003EP0665752B1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof
06/04/2003EP0571602B1 Dimer of molecular variant of apolipoprotein and processes for the production thereof
06/04/2003CN1422283A Glycosaminoglycans derived from the K5 polysaccharide having high anticoagulant and antithrombotic activity and process for their preparation
06/04/2003CN1422273A 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases
06/04/2003CN1422270A Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines
06/04/2003CN1422269A 1H-imidazopyridine derivatives
06/04/2003CN1422267A Processes for the preparation of thiazolidinedione derivatives and intermediates
06/04/2003CN1422263A Estrogen agonist/antagonist metabolites
06/04/2003CN1422262A 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
06/04/2003CN1422260A 2-guanidino-4-arylchinazolines as NHE-3 inhibitors
06/04/2003CN1422246A Malonamic acids and derivatives thereof as thyroid receptor ligands
06/04/2003CN1422230A Infusion packet with useful and decorative element, support member, delivery system and method
06/04/2003CN1422164A Preparations for preventing bile acid diarrhea
06/04/2003CN1422161A New combination of a beta blocker and a cholesterol-lowering agent
06/04/2003CN1422152A Combination of organic compound
06/04/2003CN1422151A Pharmaceutical composition comprising fluvastatin
06/04/2003CN1422125A Composition comprising free amino acids
06/04/2003CN1422122A Method for the fractionation of oil and polar lipid-containing native raw material
06/04/2003CN1421246A Recombinant human insulin compound, its prepn and medicine composition containing the compound
06/04/2003CN1421238A Natural bioreaction regulator with the functions of resisting cancer, resisting free radical damage and regulating immunity
06/04/2003CN1421232A Nutritive health food with functions of reducing blood fat and delaying senility and its prepn process
06/04/2003CN1421228A Tea, medicated tea and buccal tablet for lowering blood pressure and reducing blood fat and their prepn process
06/04/2003CN1421226A Application of Hibiscus sabdariffa Linn extractive in preparing medicine for inhibiting cardiac and cerebral vascular diseases
06/04/2003CN1421215A Health care composition for preventing and treating cadiac vascular diseases and its use
06/04/2003CN1110558C Novel growth/differentiation factor of the TGF-ÔÇÿbetaÔÇÖfamily
06/04/2003CN1110497C Di-or triaza-spiral [4,5] decane derivative
06/04/2003CN1110496C Tetrahydro Gamma-carbolines compound
06/04/2003CN1110494C Novel active benzothiepines having inhibitors forileal bile acid transfer and taurocholate salt adsorption
06/04/2003CN1110321C Enteric insulin capsule for treating diabetes
06/03/2003US6573293 Anticancer agents
06/03/2003US6573287 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
06/03/2003US6573283 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-1,3-diazacyclopenta[a]naphthalene
06/03/2003US6573262 Compounds for treating mammals infected with HIV virus
06/03/2003US6573255 Vitamin D analogues
06/03/2003US6573239 Compound comprising 15 to 26-residue peptide or peptide analogue which forms amphipathic alpha-helix in presence of lipids and exhibits specified lecithin:cholesterol acyltransferase activation activity
06/03/2003US6573096 Continuous cell lines which produce monospecific antibodies that specifically bind an epitope of a human dipeptidyl peptidase IV and thereby inhibit angiogenesis; use in treatment of cancer
06/03/2003US6572888 Controlled release lipoic acid
06/03/2003US6572876 Soy protein, isoflavone and plant sterol coadministered for atherosclerosis prevention
06/03/2003US6572850 Treating obesity by administering a polyether substituted with a pendant B-lactone group;reduction in fat hydrolysis and absorption
06/03/2003CA2223625C Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
06/03/2003CA2076424C Phosphoinositol-glycan-peptide with insulin-like action
05/2003
05/30/2003WO2003044524A2 Methods and means for influencing intracellular communication and intracellular organelle transport
05/30/2003WO2003044170A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/30/2003WO2003044021A2 Substituted indolizine-like compounds and methods of use
05/30/2003WO2003044017A1 Beta 3 adrenergic agonists
05/30/2003WO2003044016A1 3-SUBSTITUTED OXINDOLE β3 AGONISTS
05/30/2003WO2003044015A2 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
05/30/2003WO2003044010A1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity
05/30/2003WO2003044009A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003WO2003044000A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003WO2003043999A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003WO2003043998A1 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases
05/30/2003WO2003043997A1 Peroxisome proliferator activated receptor alpha agonists
05/30/2003WO2003043992A1 4-oxoquinoline derivatives
05/30/2003WO2003043988A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
05/30/2003WO2003043985A1 Heterocyclic compounds and methods of use
05/30/2003WO2003043981A1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors
05/30/2003WO2003043972A2 Functional acylglycerides
05/30/2003WO2003043615A2 Hypertonia treatment during the acute phase of a cerebrovascular accident
05/30/2003WO2003043613A2 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents
05/30/2003WO2003043604A1 Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid
1 ... 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 ... 1298